GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Marketable Securities

G.Barekat Pharm (XTEH:BRKT1) Marketable Securities : IRR2,959,761 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. G.Barekat Pharm's Marketable Securities for the quarter that ended in Mar. 2017 was IRR2,959,761 Mil.

G.Barekat Pharm's annual Marketable Securities stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR2,959,761 Mil).


G.Barekat Pharm Marketable Securities Historical Data

The historical data trend for G.Barekat Pharm's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Marketable Securities Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Marketable Securities
- 2,959,761.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Marketable Securities - 2,959,761.00

G.Barekat Pharm Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


G.Barekat Pharm  (XTEH:BRKT1) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


G.Barekat Pharm Marketable Securities Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines